Findings Participants and Intervention: Between October 5, 2018, and February 1, 2019, 304 individuals were randomly assigned to either receive semaglutide 2.4 mg (n = 152) or placebo (n = 152) and were encompassed in the comprehensive analysis set (comprising all randomized individuals as per the intention-to-treat principle)
Muscle tissue boosts metabolism
Semaglutide binds to GLP-1 receptors in the pancreas, stimulating insulin secretion in a glucose-dependent manner whilst suppressing glucagon release
Fat may accumulate underneath these lines and contribute to the skins dimpled appearance
[23:58] C Didn'T the enough point
Lack of resistance training, low protein, older age, repeated dieting, illness, and hormone changes can increase the risk